Mission Bio - About the company
Mission Bio is a series C company based in San Francisco (United States), founded in 2014 by Charlie Silver and Adam Sciambi. It operates as a Provider of single cell multiomics platform for genotypic and phenotypic analysis. Mission Bio has raised $120M in funding from investors like Mayfield, Agilent and Life Science Angels. The company has 79 active competitors, including 31 funded and 9 that have exited. Its top competitors include companies like 10X Genomics, Atrandi Biosciences and LUMICKS.
Company Details
Provider of a single-cell multi-omics platform for genotypic and phenotypic analysis. The company's proprietary Tapestri platform enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins for the precise treatment of cancer. Also, it offers DNA & protein panels, and Pharma Assay Development (PAD) Services.
- Website
- www.missionbio.com/
- Social
- Email ID
- *****@missionbio.com
- Phone Number
- +1 **********
- Registered Address
- South San Francisco, California
Key Metrics
Founded Year
2014
Location
San Francisco, United States
Stage
Series C
Total Funding
$120M in 13 rounds
Latest Funding Round
Ranked
2nd among 79 active competitors
Employee Count
91 as on Jul 31, 2026
Similar Companies
Legal entities associated with Mission Bio
Mission Bio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Mission Bio, Inc. CIN: 462503741 , United States, Active | Dec 31, 2010 | - | 58 (As on Dec 31, 2024) | - |
Sign up to download Mission Bio's company profile
Mission Bio's funding and investors
Mission Bio has raised a total funding of $120M over 13 rounds. Its first funding round was on Aug 04, 2014. Its latest funding round was a Series C round on Aug 05, 2025 for $*****. 1 investor participated in its latest round. Mission Bio has 31 institutional investors.
Here is the list of recent funding rounds of Mission Bio:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 05, 2025 | 2498435 | Series C | 3346395 | 1973950 | 6804813 | 8376102 |
Aug 13, 2020 | 8894740 | Series C | 2340149 | 3771005 | 1646055 | |
Oct 10, 2019 | 2485284 | Grant (prize money) | 8711094 | 9334255 | 8405802 |
Access funding benchmarks and valuations. Sign up today!View details of Mission Bio's funding rounds and investors
Mission Bio's founders and board of directors
Founder? Claim ProfileThe founders of Mission Bio are Charlie Silver and Adam Sciambi. Brian Kim is the CEO of Mission Bio.
Here are the details of Mission Bio's key team members:
- Charlie Silver: Co-Founder of Mission Bio.
- Adam Sciambi: Co-Founder & Chief Technology Officer of Mission Bio. Contact Info: 1 email address
Mission Bio's Board of Directors
Mission Bio's board has 7 active members. Charles Silver, Urshit Parikh, Paul Billings, M.D., Ph.D., Brock Siegel, Ph.D., Adam Abate, Ph.D., Maneesh Jain, Ph.D. and Allison Ballmer are independent board members.Here is the list of Mission Bio's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 9y 0m | |
qnxshum | Independent board member | - | Current | 5y 4m |
pl{nfzw | Independent board member | - | Current | 7y 7m |
titoinx | Independent board member | - | Current | 8y 1m |
wm{jspi | Independent board member | - | Current | 8y 2m |
miepspz | Independent board member | - | Current | 7y 8m |
koird{v | Independent board member | - | Current | 1y 6m |
View details of Mission Bio's Founder profiles and Board Members
Mission Bio's employee count trend
Mission Bio has 91 employees as of Jul 26. Here is Mission Bio's employee count trend over the years:
Uncover Mission Bio's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Mission Bio's Competitors and alternates
Top competitors of Mission Bio include 10X Genomics, Atrandi Biosciences and LUMICKS. Here is the list of Top 10 competitors of Mission Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | 10X Genomics 2012, Pleasanton (United States), Public | Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis | $243M | 77/100 | |
2nd | Mission Bio 2014, San Francisco (United States), Series C | Provider of single cell multiomics platform for genotypic and phenotypic analysis | $120M | 65/100 | |
3rd |  Atrandi Biosciences 2016, Vilnius (Lithuania), Series A | A life sciences tool company transforming single-cell research with its patented Semi-Permeable Capsule(SPC) technology, enabling high-throughput and multi-step workflows | $31M | 64/100 | |
4th | LUMICKS 2014, Amsterdam (Netherlands), Series D | Manufacturer of optical tweezers for single molecule analysis instruments | $93.4M | 63/100 | |
5th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
6th |  Xcell Biosciences 2012, San Francisco (United States), Series B | Developer of cell culture analysis device for cancer research | $40.9M | 59/100 | |
7th | Biolog 1984, Hayward (United States), Series A | Provider of cell-based phenotyping technologies and assays | $33.6M | 58/100 | |
8th | Lightcast 2019, Cambridge (United Kingdom), Series B | Developer of single-cell functional analysis using a droplet-based platform | $134M | 58/100 | |
9th | IsoPlexis 2012, New Haven (United States), Acquired | Developer of multiplexed single-cell analysis tools for the diagnostics and life science research | $186M | 54/100 | |
10th | Axion Biosystems 2007, Atlanta (United States), Acquired | Develops multi-electrode array technology to provide access to cellular information analysis | $20.3M | 53/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Mission Bio's competitors? Click here to see the top ones
Mission Bio's Investments and acquisitions
Mission Bio has made no investments or acquisitions yet.
Reports related to Mission Bio
Here is the latest report on Mission Bio's sector:
News related to Mission Bio
Filter this listMedia has covered Mission Bio for a total of 7 events in the last 1 year, 2 of them have been about company updates and 2 about partnerships.
•
Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell MultiomicsBusiness Wire•Jun 09, 2026•Human Cell Atlas, Mission Bio
•
•
Single-Cell Method Maps Pre-Malignant Mutations in Solid TissuesTechnology Networks•Jan 15, 2026•Weill Cornell Medicine, Mission Bio
•
•
Mission Bio Appoints Dr. Zivjena Vucetic as Chief Medical OfficerBusiness Wire•Oct 09, 2025•Mission Bio
•
Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansionintelligence360•Aug 21, 2025•Mission Bio
•
Mission Bio Receives Equity Financing From Ally Bridge Group
FinSMEs•Aug 06, 2025•Mission Bio, Ally Bridge Group
•
•
Mission Bio Launches First-of-its-kind Single-cell Genome Integrity SolutionHIT Consultant•Sep 26, 2024•Mission Bio
•
Mission Bio’s Tapestri Platform Utilized for Advancements in Gene-Edited T-Cell TherapyBusiness Wire•Aug 20, 2024•Mission Bio
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Mission Bio
Explore our recently published companies
- Bandhan TMX - Bhavnagar based, 2004 founded, Unfunded company
- Schauenburg - South Africa based, Unfunded company
- Proyector24.es - Barcelona based, Unfunded company
- Women Fitness - Agra based, 2000 founded, Unfunded company
- Dr. Reddy's in Netherlands - Netherlands based, 1984 founded, Public company
- Slummy Single Mummy - Taunton based, 2009 founded, Unfunded company
